Diosmin地奥司明,520-27-4

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Diosmin

CAS No. : 520-27-4

MCE 国际站：Diosmin

产品活性：Diosmin 是在各种柑橘类水果中发现的类黄酮，也是芳烃受体 (AhR) 的激动剂。

研究领域：Immunology/Inflammation

作用靶点：Aryl Hydrocarbon Receptor

In Vitro: Treatment with Diosmin causes a dose dependent increase in the amount of adducts formed (up to a 7-fold increase in adducts at 5 μM Diosmin). At 5 μM, Diosmin increases the cytotoxicity of 7,12-dimethylbenz(a)anthracene, shifting the IC₅₀ from an estimated 1.2 μM to 400 nM. Diosmin is not cytotoxic in itself at the concentrations tested. Diosmin causes an increase in CYPIAI activity in MCF-7 cells in a time- and dose-dependent fashion. Diosmin causes a dose-dependent increase in CYPIAI mRNA after 24 h of incubation, causes a long-lasting increase in CYPIAI mRNA accumulation that reaches its peak after 48 h of incubation.

In Vivo: Diosmin significantly decreases the malondialdehyde (MDA) levels and increases the activities of total-superoxide dismutase (T-SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) in the retina of rats compare with the ischemia group (P<0.05), and suppresses the ischemia/reperfusion (I/R)-induced reduction in the a- and b-wave amplitudes of the electroretinograms (ERGs) (P<0.05). The thickness of the entire retina, inner nuclear layer, inner plexiform layer, and outer retinal layer and the number of cells in the ganglion cell layer are significantly less after I/R injury (P<0.05), and Diosmin remarkably ameliorates these changes on retinal morphology. Diosmin also attenuates the I/R-induced loss of retinal ganglion cells (RGCs) of the rat retina (P<0.05).

相关产品：Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  Glycoside Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Medicine Food Homology Compound Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Flavonoids Library  |  Transcription Factor-Targeted Library  |  Food-Sourced Compound Library   |  Rare Diseases Drug Library  |  Anti-Cancer Natural Product Library  |  Anti-inflammatory Traditional Chinese Medicine Active Compound Library  |  Plant-Sourced Natural Product Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Osteogenesis Compound Library  |  Off-patent Drug Library  |  FDA-Approved Traditional Chinese Medicine Active Compound Library  |  PD98059  |  CH-223191  |  FICZ  |  Pifithrin-α hydrobromide  |  L-Kynurenine  |  Tapinarof  |  StemRegenin 1  |  ITE  |  BAY 2416964  |  Indole-3-carbinol  |  Carbidopa  |  GNF351  |  VAF347  |  BAY-218  |  Indole-3-pyruvic acid  |  Skatole  |  PDM2  |  β-Naphthoflavone  |  AHR antagonist 2  |  Benzyl butyl phthalate  |  AHR antagonist 5  |  1,4-Chrysenequinone  |  YL-109  |  6,2',4'-Trimethoxyflavone  |  D-Kynurenine  |  AhR agonist 2  |  Brevifolincarboxylic acid  |  CAY 10465  |  KYN-101

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds